GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » Gross Profit

NGL Fine-Chem (BOM:524774) Gross Profit : ₹1,799 Mil (TTM As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem Gross Profit?

NGL Fine-Chem's gross profit for the three months ended in Mar. 2024 was ₹522 Mil. NGL Fine-Chem's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,799 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. NGL Fine-Chem's gross profit for the three months ended in Mar. 2024 was ₹522 Mil. NGL Fine-Chem's Revenue for the three months ended in Mar. 2024 was ₹995 Mil. Therefore, NGL Fine-Chem's Gross Margin % for the quarter that ended in Mar. 2024 was 52.44%.

NGL Fine-Chem had a gross margin of 52.44% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of NGL Fine-Chem was 60.53%. The lowest was 49.54%. And the median was 57.20%.

Warning Sign:

NGL Fine-Chem Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.8%.


NGL Fine-Chem Gross Profit Historical Data

The historical data trend for NGL Fine-Chem's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem Gross Profit Chart

NGL Fine-Chem Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 845.88 1,526.57 1,705.12 1,377.60 1,800.02

NGL Fine-Chem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 432.15 371.16 439.75 466.97 521.60

Competitive Comparison of NGL Fine-Chem's Gross Profit

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NGL Fine-Chem's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Gross Profit distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's Gross Profit falls into.



NGL Fine-Chem Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

NGL Fine-Chem's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=3386.884 - 1586.868
=1,800

NGL Fine-Chem's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=994.617 - 473.02
=522

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,799 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

NGL Fine-Chem's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=522 / 994.617
=52.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


NGL Fine-Chem  (BOM:524774) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

NGL Fine-Chem had a gross margin of 52.44% for the quarter that ended in Mar. 2024 => Durable competitive advantage


NGL Fine-Chem Gross Profit Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


NGL Fine-Chem (BOM:524774) Business Description

Traded in Other Exchanges
Address
301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines